Settore farmaceutico

Condividiamo la cura con il mondo

Migliora l'accesso, la performance e l'affidabilità ricorrendo alla logistica specializzata per il settore prodotti farmaceutici e sanitari.

Reducing GHG emissions in global logistics with Novo Nordisk

Discover how Novo Nordisk, together with Maersk, is transforming supply chains to lower greenhouse gas (GHG) emissions. Watch the video to learn about our efforts and ongoing journey towards decarbonisation in logistics.

Why temperature control and intervention is a life-saver for pharmaceutical cargo

Temperature control and timely intervention are critical to ensure the integrity of pharmaceutical cargo. Even slight deviations can compromise the quality of life-saving medicines, disrupt their movement, and set companies back. For a deep-dive into the strategies and technologies that safeguard these vital shipments, read an insightful article by our pharma specialist Sebastian Steinmueller.
female-worker-holding-box

AI and Pharma: the next best duo

Considering how artificial intelligence is already revolutionising all industries, how can AI change the pharmaceutical industry and its supply chains? What are the benefits and challenges? Explore the 7 ways artificial intelligence can boost the pharmaceutical industry in this research piece.
Macro photography of glasses on tray

The importance of visibility for pharma supply chains

Time and quality control are key for pharma supply chains given the particularity of their cargo, but what role does visibility play? What exactly does visibility mean for pharma supply chains? In this research piece, see how better data can help visibility and what the future holds.
Medical professionals in safety suits working in a pharmaceutical laboratory

The ever-evolving cold chain needs of the pharma industry

Healthcare expenditure in the European Union is projected to surge to a staggering 350% by 2050. This seismic shift is reshaping the pharmaceutical landscape, propelling global cold chain investments to an anticipated 21.3 billion USD. But how are companies adapting? Join us as we uncover the transformative impact of market innovations on pharmaceutical logistics, guided by insights from Gaëtan Van Exem, Global Vertical Head of Pharma and Healthcare. 

How a global pharma company reduced their GHG emissions 

By choosing Maersk ECO Delivery Ocean, this pharma company was able to get closer to their decarbonisation goals while still delivering essential care all around the world. 
Maersk ship

Transforming pharma supply chains for the future 

Read our latest article by Gaetan Van Exem, Global Vertical Head, Pharma and Healthcare Cold Chain Vertical which explains the vital role of trusted partnerships and truly integrated logistics in building reliable and resilient pharma cold chain solutions. 
Ship yard

The great Indian pharma story

India is a global pharmaceutical powerhouse, on course to being a $450 billion industry by 2047. The country contributes to over 20% of the world's drug supply chain and manufactures over 60% of the global demand for vaccines. What makes the pharma industry tick in India? How are the latest innovations in technology changing the face of how the sector is run and the medicines transported? What supply chain challenges does it encounter?
Read our article for a comprehensive understanding of the latest developments and challenges in the Indian pharma industry.

Gestire, connettere, semplificare

Le aziende farmaceutiche e sanitarie leader al mondo si affidano a Maersk per una spedizione sicura dei loro prodotto, in qualsiasi parte del mondo. Offrendo vasta esperienza, conformità al GDP, soluzioni cold chain dalla fabbrica alla farmacia, equipment d'avanguardia, impegno per la sostenibilità a lungo termine, siamo i tuoi partner per la logistica farmaceutica. Segui la supply chain farmaceutica nella nostra infografica per vedere come ci impegniamo fino in fondo.
Infografica

Connettere le supply chain in modi nuovi nei settori farmaceutica e sanità

Tra 20 anni, quando guarderemo in retrospettiva l'evoluzione delle supply chain globali, saranno evidenti due periodi distinti: pre-COVID-19 e post-COVID-19. Sì, ci sono state pandemie in passato, ma nessuna nei tempi nostri, in un mondo moderna e globalizzato, dove il commercio transfrontaliero costituisce il 50% del GDP. Non abbiamo mai avuto una supply chain con un numero così alto di parti in movimento attraverso un numero così alto di Paesi con un numero così alto di parti interessate coinvolte. Inoltre la supply chain non è mai stata così tanto sotto pressione come nei tempi attuali, a meno che non si considerino gli esercizi teoretici e i piani di emergenza dell'accademia e dei responsabili del rischio.

Nei settori come quelli farmaceutica e sanità, i professionisti bilanciano la necessità di una risposta reattiva progettando un futuro più affidabile, trasparente e intelligente per le loro supply chain. Affinché ciò avvenga, i business hanno bisogno di valutare l'intera supply chain, dalla produzione alla consegna, alla dogana, al magazzino, fino al cliente finale.

In questo eBook valutiamo le innovazioni e le evoluzioni più recenti e come probabilmente sarà il futuro della logistica farmaceutica e sanitaria nel complesso. Evidenziamo alcune delle aree chiave in cui Maersk promuove l'innovazione end-to-end tramite evoluzioni in ambito di processi, tecnologia e collaborazione.

Connettere le supply chain in modi nuovi nei settori farmaceutica e sanità

Re-evaluating the modal mix for pharmaceutical supply chains

Transporting the most fragile, high-value, regulated cargo in the world is complex. Even more so when you need to roll out billions of doses of a vaccine across continents to every person on the planet. Add to that the pressures of running a supply chain focused on reducing greenhouse gas (GHG) emissions, and pharma companies could find themselves in a dilemma. Unless they add a healthy dose of shipping to their modal mix. It’s reliable, makes essential products accessible to patients around the globe, and emits less GHG emissions than most other modes of transportation, such as air transportation.
Re-evaluating the modal mix for pharmaceutical supply chains